Specified Sedative Completed Phase 4 Trials for Bupivacaine (DB00297)

IndicationStatusPhase
DBCOND0077361 (Specified Sedative)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02463929Dyphenhidramine Effect on Prevention of Sevoflurane Induced Post Anesthesia Agitation in PediatricPrevention